About
CardioSignal is a health technology brand developed by Precordior, a Finnish-American company specializing in digital cardiac biomarker solutions. The company focuses on early detection and remote monitoring of heart diseases using patented technology that measures cardiac motion and function through smartphone motion sensors. Precordior holds over 30 patents and is certified in quality management and information security. The CardioSignal app is a CE-certified class IIa medical device designed to detect atrial fibrillation (AFib) by analyzing micro-movements of the chest captured by a smartphone over 60 seconds. The technology is expanding to include detection of other cardiovascular conditions like heart failure and coronary artery disease. CardioSignal aims to enhance primary care and home monitoring, allowing healthcare professionals to assess cardiac health remotely with high accuracy. The company has established partnerships with organizations like OMRON Healthcare and JISEKI Health, and it has received recognition from the American Heart Association and the Mayo Clinic. CardioSignal is dedicated to making heart health monitoring more accessible, addressing the global burden of cardiovascular diseases.
Technologies
Keywords
Company Information
-
Employees 23
-
Founded 2016
Location
Turku, Finland
